type here...

Tag:#LYPHE Group

Medicinal Cannabis

From Flowers To Pharma – How Europe Is Forging Its Own Medicinal Cannabis Identity

As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US. AFTER picking up their script from a...
BusinessCann -
Press Releases

LYPHE Group Opens Registration To Patient Representative Board

IN an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across the organisation - and...
BusinessCann -
Medicinal Cannabis

LYPHE Group Opens Swiss Division With Germany And Poland To Follow By End Of Year

ONE of the UK’s fastest growing and largest cannabis companies has launched its first European operation with more to follow over the coming months. The...
Peter -
News

European Expansion For UK Medical Cannabis Group With Domestic Patient Numbers Set To Hit 300,000

Less than two years after launching, UK-based medical cannabis company LYPHE Group has emerged as a leading player in the patient care field, and...
Jane Hall -
Medicinal Cannabis

Huge Rise In UK Medical Cannabis Imports As Private Sector Steps-Up To Meet Patient Demand

NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling...
Peter -
Markets

Market Round-Up; Branding Challenge – ‘What Gets Me High? Not ‘Who Makes It’. Organigram, Aurora, Lyphe Group et al

A THRIVING black market and cloying limits on sales and advertising are restricting cannabis brand recognition in the fast-growing Canadian legal market place. Bloomberg reports...
Sue Kirby -

Latest news

Press Releases

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...
- Advertisement -spot_imgspot_img
Analysis

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...
Events

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Must read

Editor Picks

Must Read

BusinessCann

About BusinessCann

BusinessCann delivers news, features, comment and analysis with the people and businesses forging Europe’s hemp, medicinal cannabis and CBD wellness sectors.

Advertise | Contact Us | Terms & Conditions | Privacy Policy | Disclaimer

Follow Us

© 2022 - BusinessCann.com. All Rights Reserved.